Identification of a New Class of FtsZ Inhibitors by Structure-Based Design and in Vitro Screening

The Filamenting temperature-sensitive mutant Z (FtsZ), an essential GTPase in bacterial cell division, is highly conserved among Gram-positive and Gram-negative bacteria and thus considered an attractive target to treat antibiotic-resistant bacterial infections. In this study, a new class of FtsZ inhibitors bearing the pyrimidine-quinuclidine scaffold was identified from structure-based virtual screening of natural product libraries. Iterative rounds of in silico studies and biological evaluation established the preliminary structure-activity relationships of the new compounds. Potent FtsZ inhibitors with low micromolar IC₅₀ and antibacterial activity against S. aureus and E. coli were found. These findings support the use of virtual screening and structure-based design for the rational development of new antibacterial agents with innovative mechanisms of action.

[1]  Anirban Bhunia,et al.  Berberine targets assembly of Escherichia coli cell division protein FtsZ. , 2008, Biochemistry.

[2]  Martin Stahl,et al.  Modifications of the scoring function in FlexX for virtual screening applications , 2000 .

[3]  José L Medina-Franco,et al.  Molecular Scaffold Analysis of Natural Products Databases in the Public Domain , 2012, Chemical biology & drug design.

[4]  R. Abagyan,et al.  Pocketome via Comprehensive Identification and Classification of Ligand Binding Envelopes* , 2005, Molecular & Cellular Proteomics.

[5]  S. Levy,et al.  Antibacterial resistance worldwide: causes, challenges and responses , 2004, Nature Medicine.

[6]  Jürgen Bajorath,et al.  Integration of virtual and high-throughput screening , 2002, Nature Reviews Drug Discovery.

[7]  R. Abagyan,et al.  Do aligned sequences share the same fold? , 1997, Journal of molecular biology.

[8]  Ian Collins,et al.  An Inhibitor of FtsZ with Potent and Selective Anti-Staphylococcal Activity , 2008, Science.

[9]  H. Erickson,et al.  FtsZ, a tubulin homologue in prokaryote cell division. , 1997, Trends in cell biology.

[10]  W. Margolin,et al.  FtsZ and the division of prokaryotic cells and organelles , 2005, Nature Reviews Molecular Cell Biology.

[11]  R. Abagyan,et al.  Biased probability Monte Carlo conformational searches and electrostatic calculations for peptides and proteins. , 1994, Journal of molecular biology.

[12]  V. Sperandio,et al.  Anti-virulence strategies to combat bacteria-mediated disease , 2010, Nature Reviews Drug Discovery.

[13]  Jan Löwe,et al.  Structural insights into the conformational variability of FtsZ. , 2007, Journal of molecular biology.

[14]  Eric Langlois,et al.  Restoring Methicillin-Resistant Staphylococcus aureus Susceptibility to β-Lactam Antibiotics , 2012, Science Translational Medicine.

[15]  Jeff Errington,et al.  Bacterial cell division: assembly, maintenance and disassembly of the Z ring , 2009, Nature Reviews Microbiology.

[16]  Dulal Panda,et al.  Sanguinarine blocks cytokinesis in bacteria by inhibiting FtsZ assembly and bundling. , 2005, Biochemistry.

[17]  Jan Löwe,et al.  Structural insights into FtsZ protofilament formation , 2004, Nature Structural &Molecular Biology.

[18]  Christopher L. Shaffer,et al.  Metabolism and Disposition of a Selective α7 Nicotinic Acetylcholine Receptor Agonist in Humans , 2007, Drug Metabolism and Disposition.

[19]  J. Concepción,et al.  In Vitro and In Vivo Activities of E5700 and ER-119884, Two Novel Orally Active Squalene Synthase Inhibitors, against Trypanosoma cruzi , 2004, Antimicrobial Agents and Chemotherapy.

[20]  E. Hamel,et al.  Effects of inhibitors of tubulin polymerization on GTP hydrolysis. , 1981, The Journal of biological chemistry.

[21]  D. Pompliano,et al.  Drugs for bad bugs: confronting the challenges of antibacterial discovery , 2007, Nature Reviews Drug Discovery.

[22]  E. Bi,et al.  FtsZ ring structure associated with division in Escherichia coli , 1991, Nature.

[23]  A. Ganesan.  The impact of natural products upon modern drug discovery. , 2008, Current opinion in chemical biology.

[24]  W. L. Jorgensen.  The Many Roles of Computation in Drug Discovery , 2004, Science.

[25]  C. Fishwick,et al.  Structure-based discovery of antibacterial drugs , 2010, Nature Reviews Microbiology.

[26]  Martin Stahl,et al.  Fluorine in Medicinal Chemistry , 2004, Chembiochem : a European journal of chemical biology.

[27]  H. Erickson,et al.  FtsZ, a prokaryotic homolog of tubulin? , 1995, Cell.

[28]  Ruben Abagyan,et al.  ALiBERO: Evolving a Team of Complementary Pocket Conformations Rather than a Single Leader , 2012, J. Chem. Inf. Model..

[29]  Jared T Shaw,et al.  Inhibitors of bacterial tubulin target bacterial membranes in vivo. , 2013, MedChemComm.

[30]  Ruben Abagyan,et al.  Docking and scoring with ICM: the benchmarking results and strategies for improvement , 2012, Journal of Computer-Aided Molecular Design.

[31]  Giuseppe Bifulco,et al.  Chrysophaentins A-H, antibacterial bisdiarylbutene macrocycles that inhibit the bacterial cell division protein FtsZ. , 2010, Journal of the American Chemical Society.

[32]  Alan L Harvey,et al.  Natural products in drug discovery. , 2008, Drug discovery today.

[33]  J. Acar,et al.  Consequences of bacterial resistance to antibiotics in medical practice. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[34]  S. Addinall,et al.  The tubulin ancestor, FtsZ, draughtsman, designer and driving force for bacterial cytokinesis. , 2002, Journal of molecular biology.

[35]  Ian Collins,et al.  Novel Inhibitors of Bacterial Cytokinesis Identified by a Cell-based Antibiotic Screening Assay* , 2005, Journal of Biological Chemistry.

[36]  B. Meyer,et al.  Group epitope mapping by saturation transfer difference NMR to identify segments of a ligand in direct contact with a protein receptor. , 2001, Journal of the American Chemical Society.

[37]  Dulal Panda,et al.  Totarol inhibits bacterial cytokinesis by perturbing the assembly dynamics of FtsZ. , 2007, Biochemistry.

[38]  T. Halgren.  Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94 , 1996, J. Comput. Chem..

[39]  Anirban Bhunia,et al.  Inhibition of bacterial cell division protein FtsZ by cinnamaldehyde. , 2007, Biochemical pharmacology.

[40]  Roberta B Carey,et al.  Invasive methicillin-resistant Staphylococcus aureus infections in the United States. , 2007, JAMA.

[41]  Simon Gibbons,et al.  The Phenolic Diterpene Totarol Inhibits Multidrug Efflux Pump Activity in Staphylococcus aureus , 2007, Antimicrobial Agents and Chemotherapy.

[42]  R. Lock,et al.  Cell-division inhibitors: new insights for future antibiotics , 2008, Nature Reviews Drug Discovery.

[43]  D. Newman,et al.  Natural products as sources of new drugs over the last 25 years. , 2007, Journal of natural products.

[44]  Ruben Abagyan,et al.  A new method for ligand docking to flexible receptors by dual alanine scanning and refinement (SCARE) , 2008, J. Comput. Aided Mol. Des..

[45]  Henrik Lund,et al.  Synthesis of antimicrobial natural products targeting FtsZ: (+/-)-dichamanetin and (+/-)-2' ''-hydroxy-5' '-benzylisouvarinol-B. , 2005, Organic letters.

[46]  Ryan Gilmour,et al.  Fluorinated quinine alkaloids: synthesis, X-ray structure analysis and antimalarial parasite chemotherapy. , 2009, Chemistry.

[47]  Amanda L. Garner,et al.  Targeting the Wolbachia Cell Division Protein FtsZ as a New Approach for Antifilarial Therapy , 2011, PLoS neglected tropical diseases.

[48]  I. Kubo,et al.  Mode of antibacterial action of totarol, a diterpene from Podocarpus nagi. , 1996, Planta medica.

[49]  A. Driessen,et al.  Non‐hydrolysable GTP‐γ‐S stabilizes the FtsZ polymer in a GDP‐bound state , 2000, Molecular microbiology.

[50]  W. Margolin,et al.  Themes and variations in prokaryotic cell division. , 2000, FEMS microbiology reviews.

[51]  Ruben Abagyan,et al.  Nuclear hormone receptor targeted virtual screening. , 2003, Journal of medicinal chemistry.

[52]  Marc W Kirschner,et al.  Targeting cell division: small-molecule inhibitors of FtsZ GTPase perturb cytokinetic ring assembly and induce bacterial lethality. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[53]  Thierry Langer,et al.  Virtual screening for the discovery of bioactive natural products , 2008, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.